Yale University

Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.

TitleExtended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.
Publication TypeJournal Article
Year of Publication2017
AuthorsSpringer, Sandra A., Angela Di Paola, Marwan M. Azar, Russell Barbour, Archana Krishnan, and Frederick L. Altice
JournalDrug and alcohol dependence
Volume174
Pagination158-170
Date Published2017 May 01
ISSN1879-0046
AbstractAlcohol use disorders (AUDs) are highly prevalent among persons living with HIV (PLH) within the criminal justice system (CJS). Extended-release naltrexone (XR-NTX) has not been previously evaluated among CJS-involved PLH with AUDs.
DOI10.1016/j.drugalcdep.2017.01.026
Alternate JournalDrug Alcohol Depend

External Links